Bladder cancer
- 1 August 1996
- journal article
- Published by Taylor & Francis in Postgraduate Medicine
- Vol. 100 (2) , 217-230
- https://doi.org/10.3810/pgm.1996.08.60
Abstract
The incidence of bladder cancer has grown over the years, presumably in part because of increasing exposure to carcinogenic agents in modern-day life. Drs Badalament and Schervish outline the latest diagnostic and staging methods for the disease and summarize treatment options for superficial, invasive, and metastatic cancers, including discussion of various methods for urinary diversion following cystectomy.Keywords
This publication has 11 references indexed in Scilit:
- Cancer statistics, 1996CA: A Cancer Journal for Clinicians, 1996
- Results of a Multicenter Trial using the BTA Test to Monitor for and Diagnose Recurrent Bladder CancerJournal of Urology, 1995
- Editorial: Transitional Cell Carcinoma: A Common Sense ApproachJournal of Urology, 1995
- Accumulation of Nuclear p53 and Tumor Progression in Bladder CancerNew England Journal of Medicine, 1994
- Neoadjuvant chemotherapy and partial cystectomy for invasive bladder cancer.Journal of Clinical Oncology, 1994
- Selective Bladder Preservation by Combination Treatment of Invasive Bladder CancerNew England Journal of Medicine, 1993
- Consensus review of the clinical utility of dna cytometry in bladder cancerCytometry, 1993
- SYSTEMIC CHEMOTHERAPY IN REGIONALLY ADVANCED BLADDER CANCERUrologic Clinics of North America, 1992
- Simultaneous detection of fluorescentin situ hybridization andin vivo incorporated brdu in a human bladder tumourThe Journal of Pathology, 1991
- The sensitivity of flow cytometry compared with conventional cytology in the detection of superficial bladder carcinomaCancer, 1987